Increased Approval Speed Under User Fee System Created $11 Bil.-$13 Bil. In Sales, Economist Tells BIO
This article was originally published in The Pink Sheet Daily
Executive Summary
The increased speed of the drug review process as a result of FDA's user fee system has had a value of $11 bil.-$13 bil. in drug sales, health economist Tomas Philipson (University of Chicago) said June 21